PR Newswire BiotechOriginal article
WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
Positive
AI Analysis
Summary
bioAffinity Technologies closed a $4 million private placement offering priced at-the-market under Nasdaq rules, with WallachBeth Capital serving as the capital markets advisor. The biotechnology company focuses on noninvasive diagnostics.
Outcome Details
Private placement offering closed at-the-market pricing under Nasdaq rules
Importance:4/10
Sentiment:
0.30
capital raiseprivate placementdiagnosticsNasdaq
Related Companies
Read the original article
Published by PR Newswire Biotech on August 14, 2026 3:45 PM